Ambrosia Biosciences
Startup · Boulder, United States
Boulder biotech developing oral small molecule GLP-1 therapies; raised $100M Series B in March 2026.
Recent activity confirmed, checked October 5, 2026.
1 relationship with other organizations documented in IE research. Members see who they are and the evidence.
In context
Ambrosia Biosciences is one of 57 startups in Boulder, Colorado listed in the Innovative EcoSystems registry, and one of 1,456 across the United States.
The registry lists 323 innovation ecosystem organizations in Boulder, Colorado in all.
Startups are young companies building new products or business models.
The United States scores 68.5 out of 100 on the IEPA (2024 edition), ranking 21 of 117 economies.
See the United States on the IEPA ↗
More startups in Boulder, Colorado
- Great Sky
Boulder - Canvas Technology
Boulder - Augur Technologies
Boulder - Quadratic
Boulder - Catalyze
Boulder - Schematic
Boulder - Credible Data
Boulder - FOMO.ai
Boulder
Elsewhere in Boulder, Colorado
- Boomtown Accelerators
Accelerator - Catalyst Law Group
Company - Asius Technologies (United States)
Corporate R&D - Startup Summer
College or training provider - Institute for Telecommunication Sciences
Government or public body - Boulder Community Hospital
Health research - Colorado Quantum Incubator
Incubator - The Studio (Boulder)
Innovation hub
More startups in the United States
- Deem
Overland Park · Closed - BNNT Materials
Newport News - Cime Therapeutics
Denver - SkyWind Solutions
Boca Raton - Cast21
Chicago - CarePilot
Leawood - BuildFactory
Cedar Rapids - BriefCatch
Arlington